5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2,3-DIHYDRO-1H-INDEN-2-OL, 95%, 100mg

6-(Dimethylphosphoryl)nicotinic acid, 98%, 1g

Acid CF3-reagent (Togni Reagent II) 1 g of active ingredient (2 g of mixture)

3-Methoxy-3-methylbutyl acetate, min. 98%, for synthesis, 2.5 L, glass packaging

4-[1-(4-Hydroxy-3,5-dimethylphenyl)-1-methylethyl]-2,6-dimethylphenol, 97.0%, 100g

2,6-Dimethylbenzonitrile>98.0%(GC)25g

2,3,5,6-Tetrachloronitrobenzene>98.0%(GC)25g

(R)-3-Methyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butan-1-amine hydrochloride, 95.0%, 250mg

(2R,3R,4R,5R)-2,3,4,5,6-Pentahydroxyhexanal, 98%, 5g

((2S,4R)-4-Fluoro-1-methylpyrrolidin-2-yl)methanol, 98%, 10g

5-Bromo-1,2,4-thiadiazole, 95.0%, 5g

(R)-Methyl 2-amino-2-(2-hydroxyphenyl)acetate hydrochloride, 98%, 100mg

2-(piperazin-1-yl)quinazolin-4(3H)-one dihydrochloride, 95.0%, 250mg